Glenmark Pharmaceuticals

Lacosamide Oral Solution, 10 mg/mL, enters the U.S. market with an annual market size of $57 million

Glenmark’s Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC), will be distributed in the US by Glenmark Therapeutics, US

Glenmark Pharmaceuticals has been ranked number 1 in dermatologists’ prescriptions in the protective emollients category and for…

When launched in India, it will be co-marketed under the brand names JABRYUS and CIBINQO by Glenmark and Pfizer respectively

The newly formed IGI features a pipeline of three innovative oncology molecules targeting multiple myeloma, acute myeloid leukemia…

Glenmark will be responsible for further developing, registering, and commercialising Envafolimab in India, Asia Pacific, Middle…

It is priced at around Rs 100 for a standard dose of 1.2 mg (per day)

The tablets will be distributed in the US by Glenmark Pharmaceuticals US

Apremilast Tablets, 10 mg, 20 mg and 30 mg, is the generic version of Otezla Tablets, 10 mg, 20 mg and 30 mg, of Amgen

Cassiopea will receive an upfront payment of $5 million, in addition to double-digit regulatory and sales milestones as well as…